Khalid A. E.
- Country
- The Netherlands
- Department
- -
Research Overview
- Evaluation of Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of LY3962681 in Healthy Volunteers and Patients with Parkinson's Disease
- Safety, Tolerability, and Pharmacokinetics of THN391 in Early Alzheimer's Disease: A Double-Blind, Randomized, Placebo-Controlled Phase 1b Study
- Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ANB033 in Patients with Celiac Disease
Data & Insights
Has run more than one trial at 3 of 16 partner sites.
Specializations
Neurodegenerative Disorders
The investigator specializes in the treatment and research of various neurodegenerative conditions, with particular emphasis on Parkinson's disease and Alzheimer's disease. Their research encompasses innovative therapeutic approaches for these progressive neurological disorders.
- Early-stage Alzheimer's interventions
- Parkinson's disease therapeutics
Their work involves evaluating novel compounds for treating neurodegenerative conditions and understanding disease progression mechanisms.
Oncology and Hepatology
The investigator conducts research in complex therapeutic areas including non-small cell lung cancer and advanced liver fibrosis. Their work extends to investigating treatments for cirrhosis and associated complications.
- Lung cancer therapeutics
- Liver disease management
Their research focuses on developing therapeutic solutions for both oncological and hepatological conditions.
Men's Health
The investigator conducts research in erectile dysfunction treatment modalities, focusing on innovative therapeutic approaches. Their work encompasses safety and efficacy evaluations of novel treatments.
- Erectile dysfunction therapeutics
- Male sexual health interventions
Their research aims to advance treatment options in male sexual health medicine.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.